# Compound Holdings I, LLC: Form D filing

Compound Holdings I, LLC, a pharmaceuticals company in Chicago, IL, filed a Form D with the SEC in 2014. The latest, on February 24, 2014, reports $412 million sold of a $412 million offering to 178 investors.

Find out what Compound Holdings I, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Compound%20Holdings%20I%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Compound%20Holdings%20I%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fcompound-holdings-i-llc-1600837)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Compound%20Holdings%20I%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Compound%20Holdings%20I%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fcompound-holdings-i-llc-1600837)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Illinois](https://specstream.ai/data/form-d/state/illinois): 1,511 rows, by operating companies, filed since November 1, 2024, $75.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/illinois
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: THREE FIRST NATIONAL PLAZA, SUITE 4600, Chicago, IL, 60602
- Phone: (908) 238-6600
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Delaware
- Year incorporated: 2013
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1600837

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 24, 2014 | New notice | $412,000,000 | $412,000,000 | $0 | 178 | Feb 12, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1600837/000160083714000001/0001600837-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Elizabeth Betten | Director |  |
| Scott Charles | Executive Officer |  |
| William Scheinler | Executive Officer |  |
| Stephen Ross | Executive Officer |  |
| Lien-Lung Sheu | Executive Officer |  |
| Nicholas Alexos | Director |  |
| Joseph Stauffer | Executive Officer |  |
| Jason Shideler | Director |  |
| Anatasios Konidaris | Executive Officer |  |
| Daniel Tasse | Executive Officer, Director |  |
| Michael Adasczik | Executive Officer |  |
| Douglas Greene | Executive Officer |  |
| Jonathan Provoost | Executive Officer |  |
| Matthew Bennett | Executive Officer |  |
| James Briggs | Executive Officer |  |
| Timothy Sullivan | Director |  |
| Matthew Holt | Director |  |

[Every Form D from the week of Feb 24, 2014](https://specstream.ai/data/form-d/week/2014-02-24) · [All recent filings in Illinois](https://specstream.ai/data/form-d/state/illinois) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Compound Holdings I, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).